Scilex Holding Company announced that it has received $101.875 million in funding from Oramed Pharmaceuticals Inc.
The company has received 101,875,000 pursuant to Regulation D and included participation from single investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.12 USD | +3.70% | -2.61% | -45.10% |
May. 24 | Sector Update: Health Care Stocks Decline Late Friday Afternoon | MT |
May. 24 | Sector Update: Health Care | MT |
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
2.17 USD | -1.36% | -5.65% | 89.38M | ||
1.12 USD | +3.70% | -2.61% | 131M | ||
1st Jan change | Capi. | |
---|---|---|
-45.10% | 131M | |
+16.93% | 79.28B | |
+7.43% | 8.74B | |
-17.73% | 4.84B | |
+56.03% | 4.74B | |
+1.31% | 3.87B | |
+18.99% | 2.46B | |
-25.43% | 2.18B | |
+14.61% | 2.09B | |
-37.31% | 1.98B |